What Researchers Did
Researchers conducted a review of existing in vivo and clinical data to evaluate the potential benefits and effectiveness of hyperbaric oxygen therapy (HBOT) for middle cerebral artery occlusion (MCAO) and cerebral ischaemia/reperfusion injury.
What They Found
The review found evidence from animal and clinical studies suggesting positive effects of hyperbaric oxygen therapy (HBOT) on neurological outcomes following cerebral ischaemia. However, the review also highlighted conflicting evidence, with some studies indicating that HBOT may not improve functional recovery after ischaemic injury.
Canadian Relevance
This review does not have a direct Canadian connection.
Study Limitations
A limitation of the current evidence base, as highlighted by this review, is the conflicting data regarding the effectiveness of hyperbaric oxygen therapy on functional recovery after ischaemic injury.